Preeclampsia Laboratory Testing Market Size to grow by USD 855.3 million between 2024-2028
The Preeclampsia Laboratory Testing Market is segmented by Product Type (Consumables and Instruments), Test (Blood test, Urine test, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW)). As per the Global Forecast research report 2024-2028 published by Technavio, the market size is estimated to grow by USD 855.3 million, at a CAGR of 8.09% during the forecast period. There are several companies that are contributing to the market as per this report. Growing need for companion diagnostics .
By Product Type, the Consumables segment is projected to dominate the market size in 2024
In the realm of preeclampsia laboratory testing, consumables and reagents play essential roles. Consumables, being indispensable components, facilitate the selection and enrichment of testing procedures. Reagents, on the other hand, are chemical substances or mixtures utilized during these procedures, offering users an intuitive interface. The consumable segment experiences significant growth due to their relatively low cost and high usage frequency. Revenue generation is further bolstered through device rentals in laboratories, with consumables being purchased on a yearly basis under agreed terms. A noteworthy trend emerges as laboratories and hospitals increasingly opt for online purchasing of consumables, thereby fueling global online sales.
For insights on company offerings- Request a sample report!
By Test, Blood test segment is expected to hold the largest market size for the year 2024
In the context of pregnancy health monitoring, laboratory testing plays a crucial role in identifying potential complications, including preeclampsia. For pregnant women between 20 and 35 weeks, doctors may recommend a blood test to assess liver and kidney function, as well as platelet count. A key indicator of preeclampsia is a decreased placental growth factor (PIGF) level in the blood. If detected, further tests are necessary for confirmation. Severe preeclampsia symptoms warrant a repeat blood test to observe changes in liver function and platelet counts. This professional and timely approach to testing ensures effective diagnosis and appropriate care for pregnant women.
Why is North America forecasted to hold the largest regional market size in 2024?
The Preeclampsia Laboratory Testing Market encompasses the production, sale, and distribution of diagnostic tests used to identify preeclampsia in pregnant women. Market growth is driven by the rising prevalence of preeclampsia, advancements in testing technologies, and increasing awareness and early diagnosis initiatives. Key players in this market include Roche Diagnostics, Siemens Healthineers, and Abbott Laboratories. These companies invest in research and development to offer accurate and efficient testing solutions to healthcare providers.
To access the valuable insights - Download the Free Sample Report
Research Analysis Overview
Preeclampsia, a pregnancy complication characterized by high blood pressure and organ dysfunction, primarily affects pregnant women. Early detection is crucial for effective disease management and ensuring the health and safety of both mother and baby. Medical technologies have advanced to offer various laboratory tests for preeclampsia diagnosis, including those for kidney and liver function, blood pressure monitoring, and detection of proteinuria. The increasing prevalence of lifestyle disorders and teenage pregnancy rates, as well as co-occurring conditions like malaria and infections, necessitate novel diagnostic technologies. POC (Point of Care) products and personalized medicinal products are gaining popularity due to their convenience and ability to provide quick results. Antenatal care centers are integrating these advanced diagnostic tools to improve patient satisfaction and treatment adherence. Raw materials suppliers play a vital role in ensuring the availability and quality of these diagnostic reagents and supplies. The preeclampsia laboratory testing market is poised for growth, driven by the increasing global population and the need for effective disease management. Continuous innovation in diagnostic technologies and the integration of AI and machine learning algorithms will further enhance the accuracy and accessibility of preeclampsia testing.
Market Research Overview
The global life sciences tools and services market encompasses businesses involved in the research and development (R&D) of a diverse range of product categories, including capital equipment, instruments, accessories, and consumables. These products are utilized in the pharmaceutical and biotechnology sectors for R&D purposes, as well as in laboratory diagnosis of various diseases. Additionally, this market includes life sciences-related services such as contract research, manufacturing, and sales. According to Technavio, the healthcare industry's total market size is determined by the consolidated revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services. The expansion of the global life science tools and services market will be fueled by several factors, including the increasing global population aging, which is projected to significantly increase the proportion of individuals over 60 years old. - The Preeclampsia Laboratory Testing Market is experiencing significant growth, fueled by the . Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
